Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC
Clinical trial NCT05951127 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05951127
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2027-10-31
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.